Related Experiment Video

Updated: Jul 7, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

[Pacemaker in MR: absolute contraindication?]

Péter Bogner1, Levente Tóth, Tamás Simor

  • 1Kaposvári Egyetem, Egészségügyi Centrum, Kaposvár. peter.bogner@sic.hu

Orvosi Hetilap
|February 29, 2008
PubMed

Insights

Magnetic Resonance Imaging (MRI) can be safely performed in pacemaker-independent patients with specific safety protocols. However, MRI remains contraindicated for pacemaker-dependent patients due to significant interactions with the magnetic fields.

Area of Science:

  • Cardiovascular Imaging and Intervention
  • Biomedical Engineering and Device Safety

Background:

  • Advancements in pacemaker technology necessitate a re-evaluation of Magnetic Resonance Imaging (MRI) contraindications.
  • Pacemakers, particularly implantable cardioverter-defibrillators (ICDs), can interact significantly with MRI scanners.
  • Understanding these interactions is crucial for patient safety during cardiac MRI examinations.

Observation:

  • In vitro studies demonstrated strong interactions between ICD pacemakers and both static and changing magnetic fields (0.35 T and 1.5 T).
  • These interactions were observed to affect pacemaker performance significantly.
  • Clinical observations of two pacemaker patients undergoing cardiac MRI were also presented.

Findings:

  • MRI examination is deemed safe for pacemaker-independent patients when specific safety protocols are followed.
  • However, MRI remains contraindicated for pacemaker-dependent patients due to significant device-field interactions.
  • Pacemaker programming and post-examination checks are essential for pacemaker-independent patients undergoing MRI.

Implications:

  • Development of a safety protocol for MRI in pacemaker patients is essential.
  • Continuous monitoring (blood pressure, ECG, pulsoximetry) and resuscitation equipment are mandatory for pacemaker-independent patients.
  • Further research may refine safety guidelines and potentially expand MRI eligibility for pacemaker patients in the future.

More Related Videos

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

Related Concept Videos

Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Conduction System of the Heart01:19

Conduction System of the Heart

Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...